rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Kazia Therapeutics Limited - American Depositary Shares

KZIA · Nasdaq

Health CareBiotechnologyNot moving yet

KZIA stood above a rising 150-day average in 29 of the last 51 weekly readings, and has been out of that trend for the last 5 weeks. It is 37.0% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 5
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
36 (+14)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 29 of 51 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders36+14 on the quarter
New · exited18 · 4
Reported value$50.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Boxer Capital Management, LLCnew · filed 14 Aug 2026560,000$7.9M+560,000
FLPUTNAM INVESTMENT MANAGEMENT COadded · filed 6 Aug 2026414,958$5.8M+272,489+191.3%
Bleichroeder LPunchanged · filed 13 Aug 2026400,000$5.6M00.0%
Ikarian Capital, LLCnew · filed 14 Aug 2026396,201$5.6M+396,201
Dauntless Investment Group, LLCadded · filed 13 Aug 2026354,208$5.0M+274,376+343.7%
Stonepine Capital Management, LLCunchanged · filed 14 Aug 2026345,179$4.9M00.0%
Point72 Asset Management, L.P.added · filed 14 Aug 2026200,300$2.3M+300+0.2%
Ensign Peak Advisors, Incnew · filed 14 Aug 2026110,778$1.6M+110,778
MILLENNIUM MANAGEMENT LLCnew · filed 14 Aug 2026101,376$1.4M+101,376
UBS Group AGadded · filed 13 Aug 202681,090$1.1M+67,156+482.0%
31 Mar 2023 – 30 Jun 2026
21835Mar 23Dec 23Sep 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

James E. Levine Company insiderChief Financial Officer · last 19 Jun 20260 · 0
Sudha Rao Company insiderChief Scientific Officer · last 19 Jun 20260 · 0
David Cain Company insiderDirector, CMC · last 8 Jan 20260 · 0
Ebru Davidson Company insiderDirector · last 8 Jan 20260 · 0
Jeffrey Bonacorda Company insiderVP, Finance and Controller · last 8 Jan 20260 · 0
John E. Friend II Company insiderChief Executive Officer · last 8 Jan 20260 · 0
Robert F. Apple Company insiderDirector · last 8 Jan 20260 · 0
Steven R. S. Coffey Company insiderDirector · last 8 Jan 20260 · 0
Josiah T. Austin Company insider10% owner · last 5 Nov 201346 · 8
El Coronado Holdings, Llc Company insider10% owner · last 29 Jul 200837 · 0

Same industry

MRNA ModernaLeading+147%
IOVA Iovance BiotherapeuticsLeading+126%
ABCL AbCellera BiologicsLeading+60%
HALO Halozyme TherapeuticsLeading+46%
XERS Xeris Biopharma HoldingsLeading+38%
ENTX Entera BioLeading+37%
HELP Helus PharmaLeading+36%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 30 Jun 2025143%

Analyst forecasts

No analyst forecasts yet.